Targeting an altered sphingolipid profile with consecutive lipotoxicity as therapeutic approach to calcific aortic valve disease
Thelma C. Rusack(University Hospital Schleswig-Holstein), Elias Rawish(German Centre for Cardiovascular Research), Christian Frerker(University Hospital Schleswig-Holstein), Thomas Stiermaier(University Hospital Schleswig-Holstein), Christoph Knosalla(Unknown), Timo Gemoll(University Hospital Schleswig-Holstein), Julica Inderhees(German Centre for Cardiovascular Research), Tobias Schmidt(Asklepios Fachklinikum Brandenburg), Ingo Eitel(University Hospital Schleswig-Holstein), Zouhair Aherrahrou(University of Southern California)
Cited by 0
Related Papers
Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease
|Nature Genetics|2011|2k
The Translational Landscape of the Human Heart
|Cell|2019|681
Outcomes in Transcatheter Aortic Valve Replacement for Bicuspid Versus Tricuspid Aortic Valve Stenosis
|Journal of the American College of Cardiology|2017|486